Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial.

Girard N, Mornex F, Bossard N, Ychou M, Chauffert B, Wautot V.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1426-32. doi: 10.1016/j.ijrobp.2009.06.053. Epub 2010 Jan 7.

PMID:
20056351
2.
3.

On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.

McGinn CJ, Lawrence TS, Zalupski MM.

Cancer. 2002 Aug 15;95(4 Suppl):933-40. Review.

4.

Gemcitabine fixed-dose rate infusion for the treatment of pancreatic carcinoma: a meta-analysis of randomized controlled trials.

Xie J, Yuan J, Lu L.

Diagn Pathol. 2014 Nov 25;9:214. doi: 10.1186/s13000-014-0214-8. Review.

5.

Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study.

Karasek P, Skacel T, Kocakova I, Bednarik O, Petruzelka L, Melichar B, Bustova I, Spurny V, Trason T.

Expert Opin Pharmacother. 2003 Apr;4(4):581-6. Review.

PMID:
12667120
6.

Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.

Crane CH, Wolff RA, Abbruzzese JL, Evans DB, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Lahoti S, Vauthey JN, Janjan NA.

Semin Oncol. 2001 Jun;28(3 Suppl 10):25-33. Review.

PMID:
11510031
7.
8.

[Combined gemcitabine and radiotherapy].

Mornex F.

Bull Cancer. 2002 Aug;89 Spec No:S127-33. Review. French.

9.

Gemcitabine: once-weekly schedule active and better tolerated than twice-weekly schedule.

Martin C, Lund B, Anderson H, Thatcher N.

Anticancer Drugs. 1996 May;7(3):351-7. Review.

PMID:
8792011
10.

Palliative chemotherapy and radiotherapy for pancreatic cancer: is It worthwhile?

van der Schelling GP, Jeekel J.

World J Surg. 1999 Sep;23(9):950-3. Review.

PMID:
10449826
11.

Therapy for regionally unresectable pancreatic cancer.

Kozuch P, Petryk M, Evans A, Bruckner HW.

Surg Clin North Am. 2001 Jun;81(3):691-7. Review.

PMID:
11459282
12.

Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer?

Zhang X, Huang HJ, Feng D, Yang DJ, Wang CM, Cai QP.

World J Gastroenterol. 2014 Dec 14;20(46):17648-55. doi: 10.3748/wjg.v20.i46.17648. Review.

13.

[IMRD therapy for patients with metastatic pancreas cancer].

Yamashita K, Takahashi Y.

Nihon Rinsho. 2006 Jan;64 Suppl 1:219-22. Review. Japanese. No abstract available.

PMID:
16457254
14.

Survival benefits of adjuvant chemotherapy with oral doxifluridine (5'-DFUR) following radiotherapy in patients with unresectable pancreatic cancer.

Tsuruta K, Okamoto A, Egawa N, Kamisawa T, Karasawa K, Takahashi T.

J Surg Oncol. 2001 Nov;78(3):202-7. Review.

PMID:
11745808
15.

Chemoradiotherapy for unresectable pancreatic cancer.

Ben-Josef E, Lawrence TS.

Int J Clin Oncol. 2008 Apr;13(2):121-6. doi: 10.1007/s10147-007-0763-x. Epub 2008 May 8. Review.

PMID:
18463955
16.

Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy.

Huguet F, Mukherjee S, Javle M.

Clin Oncol (R Coll Radiol). 2014 Sep;26(9):560-8. doi: 10.1016/j.clon.2014.06.002. Epub 2014 Jul 4. Review.

PMID:
25001636
17.

[Radiation therapy in pancreatic cancer].

Chie EK.

Korean J Gastroenterol. 2008 Feb;51(2):101-10. Review. Korean.

18.

[Combined radiotherapy and gemcitabine. Evaluation of clinical data based on experimental knowledge].

Mose S, Class R, Weber HW, Oszvald A, Rahn A, Brady LW, Böttcher HD.

Strahlenther Onkol. 2002 Feb;178(2):59-70. Review. German.

PMID:
11942039
19.

Gemcitabine-induced radiation recall.

Jeter MD, Jänne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R.

Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):394-400. Review.

PMID:
12023144
20.

Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature.

Tan DH, Bunce PE, Liles WC, Gold WL.

Clin Infect Dis. 2007 Sep 1;45(5):e72-6. Epub 2007 Jul 20. Review.

PMID:
17682983

Supplemental Content

Support Center